Transcriptional regulation in B cell differentiation

Critical Reviews in Immunology

Volumn 19, Issue 2, 1999, Pages 127-153

  Liberg, David ^a   Sigvardsson, Mikael ^a  

^a NONE

Author keywords

B cell development; Enhancers; Promoters; Transcription factors

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD72 ANTIGEN; DNA NUCLEOTIDYLEXOTRANSFERASE; IMMUNOGLOBULIN; TRANSCRIPTION FACTOR;

ALLELE; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL LINEAGE; ENHANCER REGION; HUMAN; IMMUNOGLOBULIN GENE; IMMUNOREGULATION; LYMPHOPOIESIS; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; MICE; TRANSCRIPTION, GENETIC;

EID: 0032966027     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (291)

1. Li, Y. S., Hayakawa, K., and Hardy, R. R., The regulated expression of B lineage associated genes during B-cell differentiation in bone marrow and fetal liver, J. Exp. Med., 178, 951-960, 1993.
2. Li, Y. S., Wasserman, R., Hayakawa, K., and Hardy, R. R., Identification of the earliest B lineage stage in mouse bone marrow, Immunity, 5, 527-535, 1996.
3. Hardy, R. R., Carmack, C. E., Shinton, S. A., Kemp, J. D., and Hayakawa, K., Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow, J. Exp. Med., 173, 1213-1225, 1991.
4. Grawunder, U., Winkler, T. H., and Melchers, F., Regulation of recombination activating gene expression during lymphocyte development, Curr. Top. Microbiol. Immunol., 217, 31-43, 1996.
5. Borst, J., Jacobs, H., and Brouns, G., Composition and function of T-cell receptor and B-cell receptor complexes on precursor lymphocytes, Curr. Opin. Immunol., 8, 181-190, 1996.
6. Rolink, A., Haasner, D., Melchers, F., and Andersson, J., The surrogate light-chain in mouse B-cell development, Int. Rev. Immunol., 13, 341-156, 1996.
7. Karasuyama, H., Rolink, A., and Melchers, F., Surrogate light-chain in B-cell development, Adv. Immunol., 63, 1-41, 1996.
8. Cyster, J. G. and Goodnow, C. C., Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment, Immunity, 6, 509-517, 1997.
9. Melchers, F., Rolink, A., Grawunder, U., Winkler, T. H., Karasuyama, H., Ghia, P., and Andersson, J., Positive and negative selection events during B lymphopoiesis, Curr. Opin. Immunol., 7, 214-227, 1995.
10. Hertz, M., Kouskoff, V., Nakamura, T., and Nemazee, D., V(D)J recombinase induction in splenic B lymphocytes is inhibited by antigen-receptor signaling, Nature, 394, 292-295, 1998.
11. Hertz, M. and Nemazee, D., Receptor editing and commitment in B lymphocytes, Curr. Opin. Immunol., 10, 208-213, 1998.
12. Papavasiliou, F., Casellas, R., Suh, H., Qin, X. F., Besmer, E., Pelanda, R., Nemazee, D., Rajewsky, K., and Nussenzweig, M. C., V(D)J recombination in mature B cells: a mechanism for altering antibody responses [see comments], Science, 278, 298-301, 1997.
13. Ohmori, H. and Hikida, M., Expression and function of recombination activating genes in mature B cells, Crit. Rev. Immunol., 18, 221-235, 1998.
14. Fanning, L., Bertrand, F. E., Steinberg, C., and Wu, G. E., Molecular mechanisms involved in receptor editing at the Ig heavy chain locus, Int. Immunol., 10, 241-246, 1998.
15. Lane, P., Development of B-cell memory and effector function, Curr. Opin. Immunol., 8, 331-335, 1996.
16. Tanchot, C., Rosado, M. M., Agenes, F., Freitas, A. A., and Rocha, B., Lymphocyte homeostasis, Semin. Immunol., 9, 331-337, 1997.
17. Liu, Y. J. and Arpin, C., Germinal center development, Immunol. Rev., 156, 111-126, 1997.
18. Takatsu, K., Cytokines involved in B-cell differentiation and their sites of action, Proc. Soc. Exp. Biol. Med., 215, 121-133, 1997.
19. Tarlinton, D., B-cell differentiation in the bone marrow and the periphery, Immunol. Rev., 137,: 203-229, 1994.
20. Slifka, M. K. and Ahmed, R., Long-lived plasma cells: a mechanism for maintaining persistent antibody production, Curr. Opin. Immunol., 10, 252-258, 1998.
21. Liu, Y. J. and Banchereau, J., Regulation of B-cell commitment to plasma cells or to memory B cells, Semin. Immunol., 9, 235-240, 1997.
22. Sprent, J., Immunological memory, Curr. Opin. Immunol., 9, 371-379, 1997.
23. Ernst, P. and Smale, S. T., Combinatorial regulation of transcription. I: General aspects of transcriptional control, Immunity, 2, 311-319, 1995.
24. Kadonaga, J. T., Eukaryotic transcription: an interlaced network of transcription factors and chromatin-modifying machines, Cell, 92, 307-313, 1998.
25. Razin, A., CpG methylation, chromatin structure, and gene silencing-a three-way connection, EMBO J., 17, 4905-4908, 1998.
26. Fraser, P. and Grosveld, F., Locus control regions, chromatin activation, and transcription, Curr. Opin. Cell. Biol., 10, 361-365, 1998.
27. Latchman, D. S., Transcription factors: an overview, Int. J. Biochem. Cell. Biol., 29, 1305-1312, 1997.
28. Tan, S. and Richmond, T. J., Eukaryotic transcription factors, Curr. Opin. Struct. Biol., 8, 41-48, 1998.
29. Boulikas, T., A compilation and classification of DNA binding sites for protein transcription factors from vertebrates, Crit. Rev. Eukaryot. Gene Expr., 4, 117-321, 1994.
30. Latchman, D. S., Transcription factors: an overview, Int. J. Exp. Pathol., 74, 417-422, 1993.
31. Singh, H., Gene targeting reveals a hierarchy of transcription factors regulating specification of lymphoid cell fates, Curr. Opin. Immunol., 8, 160-165, 1996.
32. Georgopoulos, K., Transcription factors required for lymphoid lineage commitment, Curr. Opin. Immunol., 9, 222-227, 1997.
33. Look, A. T., Oncogenic transcription factors in the human acute leukemias, Science, 278, 1059-1064, 1997.
34. Rabbitts, T. H., Chromosomal translocations in human cancer, Nature, 372, 143-149, 1994.
35. Zhuang, Y., Soriano, P., and Weintraub, H., The helix-loop-helix gene E2A is required for B cell formation, Cell, 79, 875-884, 1994.
36. Bain, G., Maandag, E. C. R., Izon, D. J., Amsen, D., Kruisbeek, A. M., Weintraub, B. C., Kroop, I., Schlissel, M. S., Feeney, A. J., van Roon, M., van der Valk, M., te Riel, H. P. J., Berns, A., and Murre, C., E2A proteins are required for proper B-cell development and initiation of immunoglobulin gene rearrangements, Cell, 79, 885-892, 1994.
37. Lin, H. and Grosschedl, R., Failure of B-cell differentiation in mice lacking the transcription factor EBF, Nature, 376, 263-267, 1995.
38. Urbánek, P., Wang, Z.-Q., Fetka, I., Wagner, E. F., and Busslinger, M., Complete block of early B-cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP, Cell, 79, 901-912, 1994.
39. Nutt, S. L., Urbanek, P., Rolink, A., and Busslinger, M., Essential functions of Pax5 (BSAP) in pro-B-cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus, Genes Dev., 11, 476-491, 1997.
40. Stanton, L. W., Watt, R., and Marcu, K. B., Translocation, breakage, and truncated transcripts of c-myc oncogene in murine plasmacytomas, Nature, 303, 401-406, 1983.
41. Rabbitts, T. H., Chromosomal breakpoints hit the spot [news], Nat. Med., 3, 496-497, 1997.
42. Hunger, S. P., Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis, Blood, 87, 1211-1224, 1996.
43. Hunger, S. P., Sun, T., Boswell, A. F., Carroll, A. J., and McGavran, L., Hyperdiploidy and E2A-PBX1 fusion in an adult with t(1;19)+ acute lymphoblastic leukemia: case report and review of the literature, Genes Chromosomes Cancer, 20, 392-398, 1997.
44. Kamps, M. P., E2A-Pbx1 induces growth, blocks differentiation, and interacts with other homeodomain proteins regulating normal differentiation, Curr. Top. Microbiol. Immunol., 220, 25-43, 1997.
45. Wang, H., Diamond, R. A., and Rothenberg, E. V., Cross-lineage expression of Ig-beta (B29) in thymocytes: positive and negative gene regulation to establish T cell identity, Proc. Natl. Acad. Sci. U.S.A., 95, 6831-6836, 1998.
46. Alt, F. W., Blackwell, T. K., and Yancopoulos, G. D., Development of the primary antibody repertoir, Science, 238, 1079, 1987.
47. Oettinger, M. A., Schatz, D. G., Gorka, C., and Baltimore, D., RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination, Science, 248, 1517-1523, 1990.
48. Schatz, D. G., Oettinger, M. A., and Baltimore, D., The V(D)J recombination activating gene, RAG-1, Cell, 59, 1035-1048, 1989.
49. Mombaerts, P., Iacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S., and Papaioannou, V. E., RAG-1-deficient mice have no mature B and T lymphocytes, Cell, 68, 869-877, 1992.
50. Shinkai, Y., Rathbun, G., Lam, K.-P., Oltz, E. M., Stewart, V., Mendehlson, M., Charron, J., Datta, M., Young, F., Stall, A. M., and Alt, F. W., RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangements, Cell, 68, 855-867, 1992.
51. Brown, S. T., Miranda, G. A., Galic, Z., Hartman, I. Z., Lyon, C. J., and Aguilera, R. J., Regulation of the RAG-1 promoter by the NF-Y transcription factor, J. Immunol., 158, 5071-5074, 1997.
52. Fuller, K. and Storb, U., Identification and characterization of the murine Rag 1 promoter, Mol. Immunol., 34, 939-954, 1997.
53. Kadesch, T., Helix-loop-helix proteins in the regulation of immunoglobulin gene transcription, Immunol. Today, 13, 31-36, 1992.
54. Murre, C., Bain, G., van Dijk, M. A., Engel, I., Furnari, B. A., Massari, M. E., Matthews, J. R., Quong, M. W., Rivera, R. R., and Stuiver, M. H., Structure and function of helix-loop-helix proteins, Biochim. Biophys. Acta, 1218, 129-135, 1994.
55. Weintraub, H., Davis, R., Tapscott, S., Thayer, M., Krause, M., Benezra, R., Blackwell, T. K., Turner, D., Rupp, R., Hollenberg, S., et al., The myoD gene family: nodal point during specification of the muscle cell lineage, Science, 251, 761-766, 1991.
56. Ephrussi, A., Church, G. M., Tonegawa, S., and Gilbert, W., B linage-specific interactions of an immunoglobulin enhancer with cellular factors in vivo, Science, 227, 134-140, 1985.
57. Murre, C., McCaw, P. S., Vaessin, H., Caudy, M., Jan, L. Y., Jan, Y. N., Cabrera, C. V., Buskin, J. N., Hauschka, S. D., Lassar, A. B., Weintraub, H., and Baltimore, D., Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence, Cell, 58, 537-544, 1989.
58. Murre, C., McCaw, P. S., and Baltimore, D., A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins, Cell, 56, 777-783, 1989.
59. Lassar, A. B., Davis, R. L., Wright, W. E., Kadesch, T., Murre, C., Voronova, A., Baltimore, D., and Weintraub, H., Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo, Cell, 66, 305-315, 1991.
60. Shen, C. P. and Kadesch, T., B-cell-specific DNA binding by an E47 homodimer, Mol. Cell. Biol., 15, 4518-4524, 1995.
61. Benezra, R., An intermoleculare disulfid bond stabilizes E2A homodimers and is required for DNA binding at physiological temperatures, Cell, 79, 1057-1067, 1994.
62. Sloan, S. R., Shen, C. P., McCarrick-Walmsley, R., and Kadesch, T., Phosphorylation of E47 as a potential determinant of B-cell-specific activity, Mol. Cell. Biol., 16: 6900-6908, 1996.
63. Schlissel, M., Voronova, A., and Baltimore, D., Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line, Genes Dev., 5, 1367-1376, 1991.
64. Choi, J. K., Shen, C.-P., Radomska, H. S., Eckhardt, L. A., and Kadesch, T., E47 activates the Ig-heavy chain and TdT loci in non-B cells, EMBO J., 15, 5014-5021, 1996.
65. Kee, B. L. and Murre, C., Induction of early B-cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12 [in process citation], J. Exp. Med., 188, 699-713, 1998.
66. Hoeppner, M. A., Gilbert, D. J., Copeland, N. G., Jenkins, N. A., Linzer, D. I., and Wu, B., Cloning and characterization of mouse CCAAT binding factor, Nucleic Acids Res., 24, 1091-1098, 1996.
67. Mantovani, R., A survey of 178 NF-Y binding CCAAT boxes, Nucleic Acids Res., 26, 1135-1143, 1998.
68. Desiderio, S. V., Yancopolous, G. D., Paskind, M., Thomas, E., Boss, M. A., Landau, N., Alt, F. W., and Baltimore, D., Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells, Nature, 311, 752-755, 1984.
69. Komori, T., Pricop, L., Hatakeyama, A., Bona, C. A., and Alt, F. W., Repertoires of antigen receptors in Tdt congenitally deficient mice, Int. Rev. Immunol., 13, 317-325, 1996.
70. Ernst, P., Hahm, K., and Smale, S. T., Both LyF-1 and an Ets protein interact with a critical promoter element in the murine terminal transferase gene, Mol. Cell. Biol., 13, 2982-2992, 1993.
71. Lo, K., Landau, N. R., and Smale, S. T., LyF-1, a transcriptional regulator that interacts with a novel class of promoters for lymphocyte-specific genes, Mol. Cell. Biol., 11, 5229-5243, 1991.
72. Georgopoulos, K., Moore, D. D., and Derfler, B., Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment, Science, 258, 808-812, 1992.
73. Hahm, K., Ernst, P., Lo, K., Kim, G. S., Turck, C., and Smale, S. T., The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene, Mol. Cell. Biol., 14, 7111-7123, 1994.
74. Wang, J. H., Nichogiannopoulou, A., Wu, L., Sun, L., Sharpe, A. H., Bigby, M., and Georgopoulos, K., Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation, Immunity, 5, 537-549, 1996.
75. Molnar, A. and Georgepoulos, K., The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins, Mol. Cell. Biol., 14, 8292-8303, 1994.
76. Ernst, P., Hahm, K., Trinh, L., Davis, J. N., Roussel, M. F., Turck, C. W., and Smale, S. T., A potential role for Elf-1 in terminal transferase gene regulation, Mol. Cell. Biol., 16, 6121-6131, 1996.
77. Papas, T. S., Bhat, N. K., Spyropoulos, D. D., Mjaatvedt, A. E., Vournakis, J., Seth, A., and Watson, D. K., Functional relationships among ETS gene family members, Leukemia, 11 (Suppl. 3), 557-566, 1997.
78. Moreau-Gachelin, F., Spi-1/PU.1: an oncogene of the Ets family, Biochim. Biophys. Acta, 1198, 149-163, 1994.
79. Kudo, A., Sakaguchi, N., and Melchers, F., Organization of the murine Ig-related lambda 5 gene transcribed selectively in pre-B lymphocytes [published erratum appears in EMBO J., 1987 Dec 20; 6(13), 4242], EMBO J., 6, 103-107, 1987.
80. Kudo, A., Sakaguchi, N., and Melchers, F., Organization of the murine Ig-related lambda 5 gene transcribed selectively in pre-B lymphocytes [published erratum appears in EMBO J., 1987 Dec 20; 6(13), 4242], EMBO J., 6, 103-107, 1987.
81. Sakaguchi, N. and Melchers, F., Lambda 5, a new light-chain-related locus selectively expressed in pre-B lymphocytes, Nature, 324, 579-582, 1986.
82. Kitamura, D., Kudo, A., Schaal, S., Muller, W., Melchers, F., and Rajewsky, K., A critical role of lambda 5 protein in B cell development, Cell, 69, 823-831, 1992.
83. Yang, J., Glozak, M. A., and Blomberg, B. B., Identification and localization of a developmental stage-specific promoter activity from the murine lambda 5 gene, J. Immunol., 155, 2498-2514, 1995.
84. Martensson, I. L. and Melchers, F., Pre-B cell-specific lambda 5 gene expression due to suppression in non pre-B cells, Int. Immunol., 6, 863-872, 1994.
85. Martensson, A. and Martensson, I. L., Early B cell factor binds to a site critical for lambda5 core enhancer activity, Eur. J. Immunol., 27, 315-320, 1997.
86. Martensson, I. L., Melchers, F., and Winkler, T. H., A transgenic marker for mouse B lymphoid precursors, J. Exp. Med., 185, 653-661, 1997.
87. Adams, B., Dorfler, P., Aguzzi, A., Kozmik, Z., Urbanek, P., Maurer-Fogy, I., and Busslinger, M., Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis, Genes Dev., 6, 1589-1607, 1992.
88. Michaelson, J. S., Singh, M., and Birshtein, B. K., B-cell lineage-specific activator protein (BSAP). A player at multiple stages of B-cell development, J. Immunol., 156, 2349-2351, 1996.
89. Neurath, M. F., Stuber, E. R., and Strober, W., BSAP: a key regulator of B-cell development and differentiation, Immunol. Today, 16, 564-569, 1995.
90. Tian, J., Okabe, T., Miyazaki, T., Takeshita, S., and Kudo, A., Pax-5 is identical to EBB-1/KLP and binds to the VpreB and lambda5 promoters as well as the KI and KII sites upstream of the Jkappa genes, Eur. J. Immunol., 27, 750-755, 1997.
91. Sigvardsson, M., O'Riordan, M., and Grosschedl, R., EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes, Immunity, 7, 25-36, 1997.
92. Hagman, J., Travis, A., and Grosschedl, R., A novel lineage-specific nuclear factor regulates mb-1 gene transcription at the early stages of B cell differentiation, EMBO J., 10, 3409-3417, 1991.
93. Hagman, J., Belanger, C., Travis, A., Turck, C. W., and Grosschedl, R., Cloning and functional characterization of early B-cell factor, a regulator of lymphocyte-specific gene expression, Genes Dev., 7, 760-773, 1993.
94. Hagman, J., Gutch, M. J., Lin, H., and Grosschedl, R., EBF contains a novel zinc coordination motif and multiple dimerization and transcriptional activation domains, EMBO J., 14, 2907-2916, 1995.
95. Brown, K. E., Guest, S. S., Smale, S. T., Hahm, K., Merkenschlager, M., and Fisher, A. G., Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin, Cell, 91, 845-854, 1997.
96. Kudo, A. and Melchers, F., A second gene, VpreB in the lambda 5 locus of the mouse, which appears to be selectively expressed in pre-B lymphocytes, EMBO J., 6, 2267-2272, 1987.
97. Dul, J. L., Argon, Y., Winkler, T., ten Boekel, E., Melchers, F., and Martensson, I. L., The murine VpreB1 and VpreB2 genes both encode a protein of the surrogate light chain and are coexpressed during B cell development, Eur. J. Immunol., 26, 906-913, 1996.
98. Okabe, T., Bauer, S. R., and Kudo, A., Pre-B lymphocyte-specific transcriptional control of the mouse VpreB gene, Eur. J. Immunol., 22, 31-36, 1992.
99. Persson, C., Martensson, A., and Martensson, I. L., Identification of a tissue- and differentiation stage-specific enhancer of the VpreB1 gene, Eur. J. Immunol., 28, 787-798, 1998.
100. Hombach, J., Lottspeich, F., and Reth, M., Identification of the genes encoding the IgM-alpha and Ig-beta components of the IgM antigen receptor complex by amino-terminal sequencing, Eur. J. Immunol., 20, 2795-2799, 1990.
101. Hombach, J., Tsubata, T., Leclercq, L., Stappert, H., and Reth, M., Molecular components of the B-cell antigen receptor complex of the IgM class, Nature, 343, 760-762, 1990.
102. Lin, J. and Justement, L. B., The MB-1/B29 heterodimer couples the B cell antigen receptor to multiple src family protein tyrosine kinases, J. Immunol., 149, 1548-1555, 1992.
103. Hermanson, G. G., Eisenberg, D., Kincade, P. W., and Wall, R., B29: a member of the immunoglobulin gene superfamily exclusively expressed on beta-lineage cells, Proc. Natl. Acad. Sci. U.S.A., 85, 6890-6894, 1988.
104. Gong, S. and Nussenzweig, M. C., Regulation of an early developmental checkpoint in the B cell pathway by Igb, Science, 272, 411-414, 1996.
105. Hermanson, G. G., Briskin, M., Sigman, D., and Wall, R., Immunoglobulin enhancer and promoter motifs 5′ of the B29 B-cell-specific gene, Proc. Natl. Acad. Sci. U.S.A., 86, 7341-7345, 1989.
106. Omori, S. A. and Wall, R., Multiple motifs regulate the B-cell-specific promoter of the B29 gene, Proc. Natl. Acad. Sci. U.S.A., 90, 11723-11727, 1993.
107. Torres, R. M., Flaswinkel, H., Reth, M., and Rajewsky, K., Aberrant B cell development and immune response in mice with a compromised BCR complex [see comments], Science, 272, 1804-1808, 1996.
108. Sakaguchi, N., Kashiwamura, S., Kimoto, M., Thalmann, P., and Melchers, F., B lymphocyte lineage-restricted expression of mb-1, a gene with CD3-like structural properties, EMBO J., 7, 3457-3464, 1988.
109. Travis, A., Hagman, J., and Grosschedl, R., Heterogeneously initiated transcription from the pre-B- and B-cell-specific mb-1 promoter: analysis of the requirement for upstream factor binding sites and initiation site sequences, Mol. Cell. Biol., 1991; 11, 5756-5766, 1991.
110. Travis, A., Hagman, J., and Grosschedl, R., Heterogeneously initiated transcription from the pre-B- and B-cell-specific mb-1 promoter: analysis of the requirement for upstream factor binding sites and initiation site sequences, Mol. Cell. Biol., 1991; 11, 5756-5766, 1991.
111. Hagman, J. and Grosschedl, R., An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene, Proc. Natl. Acad. Sci. U.S.A., 89, 8889-8893, 1992.
112. Fitzsimmons, D., Hodsdon, W., Wheat, W., Maira, S. M., Wasylyk, B., and Hagman, J., Pax-5 (BSAP) recruits Ets protooncogene family proteins to form functional ternary complexes on a B-cell-specific promoter, Genes Dev., 1996; 10, 2198-2211, 1996.
113. Fitzsimmons, D., Hodsdon, W., Wheat, W., Maira, S. M., Wasylyk, B., and Hagman, J., Pax-5 (BSAP) recruits Ets protooncogene family proteins to form functional ternary complexes on a B-cell-specific promoter, Genes Dev., 1996; 10, 2198-2211, 1996.
114. Dymecki, S. M., Niederhuber, J. E., and Desiderio, S. V., Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells, Science, 247, 332-336, 1990.
115. Dymecki, S. M., Zwollo, P., Zeller, K., Kuhajda, F. P., and Desiderio, S. V., Structure and developmental regulation of the B-lymphoid tyrosine kinase gene blk, J. Biol. Chem., 267, 4815-4823, 1992.
116. Zwollo, P. and Desiderio, S., Specific recognition of the blk promoter by the B-lymphoid transcription factor B-cell-specific activator protein, J. Biol. Chem., 269, 15310-15317, 1994.
117. Zwollo, P., Rao, S., Wallin, J. J., Gackstetter, E. R., and Koshland, M. E., The transcription factor NF-kappaB/p50 interacts with the blk gene during B cell activation, J. Biol. Chem., 273, 18647-18655, 1998.
118. Engel, P., Zhou, L. J., Ord, D. C., Sato, S., Koller, B., and Tedder, T. F., Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule, Immunity, 3, 39-50, 1995.
119. Tedder, T. F. and Isaacs, C. M., Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily, J. Immunol., 143, 712-717, 1989.
120. Kozmik, Z., Wang, S., Dorfler, P., Adams, B., and Busslinger, M., The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP, Mol. Cell. Biol., 12, 2662-2672, 1992.
121. Riva, A., Wilson, G. L., and Kehrl, J. H., In vivo footprinting and mutational analysis of the proximal CD19 promoter reveal important roles for an SP1/ Egr-1 binding site and a novel site termed the PyG box, J. Immunol., 159, 1284-1292, 1997.
122. Nutt, S. L., Morrison, A. M., Dorfler, P., Rolink, A., and Busslinger, M., Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments, EMBO J., 17, 2319-2333, 1998.
123. Stamenkovic, I., Clark, E. A., and Seed, B., A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas, EMBO J., 8, 1403-1410, 1989.
124. Nakayama, E., von Hoegen, I., and Parnes, J. R., Sequence of the Lyb-2 B-cell differentiation antigen defines a gene superfamily of receptors with inverted membrane orientation, Proc. Natl. Acad. Sci. U.S.A., 86, 1352-1356, 1989.
125. Van de Velde, H., von Hoegen, I., Luo, W., Parnes, J. R., and Thielemans, K., The B-cell surface protein CD72/Lyb-2 is the ligand for CD5 [see comments], Nature, 351, 662-665, 1991.
126. Gordon, J., B-cell signaling via the C-type lectins CD23 and CD72, Immunol. Today, 15, 411-417, 1994.
127. Ying, H., Chang, J. F., and Parnes, J. R., PU.1/Spi-1 is essential for the B cell-specific activity of the mouse CD72 promoter, J. Immunol., 160, 2287-2296, 1998.
128. Tedder, T. F., Klejman, G., Disteche, C. M., Adler, D. A., Schlossman, S. F., and Saito, H., Cloning of a complementary DNA encoding a new mouse B lymphocyte differentiation antigen, homologous to the human B1 (CD20) antigen, and localization of the gene to chromosome 19, J. Immunol., 141, 4388-4394, 1988.
129. Tedder, T. F., Streuli, M., Schlossman, S. F., and Saito, H., Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes, Proc. Natl. Acad. Sci. U.S.A., 85, 208-212, 1988.
130. Tedder, T. F. and Engel, P., CD20: a regulator of cell-cycle progression of B lymphocytes, Immunol. Today, 15, 450-454, 1994.
131. Tedder, T. F., Disteche, C. M., Louie, E., Adler, D. A., Croce, C. M., Schlossman, S. F., and Saito, H., The gene that encodes the human CD20 (B1) differentiation antigen is located on chromosome 11 near the t(11;14)(q13;q32) translocation site, J. Immunol., 142, 2555-2559, 1989.
132. Rieckmann, P., Wilson, G. L., Thevenin, C., Hong, J. X., and Kehrl, J. H., Analysis of cis-acting elements present in the CD20/B1 antigen promoter, J. Immunol., 147, 3994-3999, 1991.
133. Thevenin, C., Lucas, B. P., Kozlow, E. J., and Kehrl, J. H., Cell type- and stage-specific expression of the CD20/B1 antigen correlates with the activity of a diverged octamer DNA motif present in its promoter, J. Biol. Chem., 268, 5949-5956, 1993.
134. Himmelmann, A., Riva, A., Wilson, G. L., Lucas, B. P., Thevenin, C., and Kehrl, J. H., PU.1/Pip and basic helix loop helix zipper transcription factors interact with binding sites in the CD20 promoter to help confer lineage- and stage-specific expression of CD20 in B lymphocytes, Blood, 90, 3984-3995, 1997.
135. Eisenbeis, C. F., Singh, H., and Storb, U., Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator, Genes Dev., 9, 1377-1387, 1995.
136. Pongubala, J., Nagulapalli, S., Klemsz, M. J., McKercher, S., Maki, R., and Atchison, M. L., PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3′ enhancer activity, Mol. Cell. Biol., 12, 368-378, 1992.
137. Eisenbeis, C., Singh, H., and Storb, U., PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin λ2-4 enhancer, Mol. Cell. Biol., 13, 6452-6461, 1993.
138. Kehrl, J. H., Riva, A., Wilson, G. L., and Thevenin, C., Molecular mechanisms regulating CD19, CD20, and CD22 gene expression, Immunol. Today, 15, 432-436, 1994.
139. Leprince, C., Draves, K. E., Geahlen, R. L., Ledbetter, J. A., and Clark, E. A., CD22 associates with the human surface IgM-B-cell antigen receptor complex, Proc. Natl. Acad. Sci. U.S.A., 90, 3236-3240, 1993.
140. Peaker, C. J. and Neuberger, M. S., Association of CD22 with the B cell antigen receptor, Eur. J. Immunol., 23, 1358-1363, 1993.
141. Wilson, G. L., Fox, C. H., Fauci, A. S., and Kehrl, J. H., cDNA cloning of the B cell membrane protein CD22: a mediator of B-B cell interactions, J. Exp. Med., 173, 137-146, 1991.
142. Nitschke, L., Carsetti, R., Ocker, B., Kohler, G., and Lamers, M. C., CD22 is a negative regulator of B-cell receptor signaling, Curr. Biol., 7, 133-143, 1997.
143. Andersson, K. B., Draves, K. E., Magaletti, D. M., Fujioka, S., Holmes, K. L., Law, C. L., and Clark, E. A., Characterization of the expression and gene promoter of CD22 in murine B cells, Eur. J. Immunol., 26, 3170-3178, 1996.
144. Wilson, G. L., Najfeld, V., Kozlow, E., Menniger, J., Ward, D., and Kehrl, J. H., Genomic structure and chromosomal mapping of the human CD22 gene, J. Immunol., 150, 5013-5024, 1993.
145. Ernst, P. and Smale, S. T., Combinatorial regulation of transcription II: The immunoglobulin mu heavy chain gene, Immunity, 2, 427-438, 1995.
146. Nelsen, B. and Sen, R., Regulation of immunoglobulin gene transcription, Int. Rev. Cytol., 133, 121-149, 1992.
147. Yancopoulos, G. D. and Alt, F. W., Developmentally controlled and tissue-specific expression of unrearranged VH gene segments, Cell, 40, 271-281, 1985.
148. Perry, R. P. and Kelley, D. E., Immunoglobulin meddenger RNA in murine cell lines that have characteristics of immature B lymphocytes, Cell, 18, 1333-1339, 1979.
149. Chen-Bettecken, U., Wecker, E., and Schimpl, A., Transcriptional control of μ- and κ-gene expression in resting and bacterial lipopolysaccharide-activated normal B cells, Immunobiology, 174, 162-176, 1987.
150. Yuan, D. and Tucker, P. W., Transcriptional regulation of the μ-δ heavy chain locus in normal murine B lymphocytes, J. Exp. Med., 160, 564-583, 1984.
151. Lennon, G. G. and Perry, R. P., The temporal order of appearance of transcripts from unrearranged and rearranged Ig genes in murine fetal liver, J. Immunol., 144, 1983-1987, 1990.
152. Cogné, M., Lansford, R., Bottaro, A., Zhang, J., Gorman, J., Young, F., Cheng, H.-L., and Alt, F. W., A class switch control region at the 3′ end of the immunoglobulin heavy chain locus, Cell, 77, 737-747, 1994.
153. Chen, J., Young, F., Bottaro, A., Stewart, V., Smith, R. K., and Alt, F. W., Mutations of the intronic IgH enhancer and its flanking sequences differentially affect accessibility of the JH locus, EMBO J., 12, 4635-4645, 1993.
154. Storb, U., Peters, A., Klotz, E., Kim, N., Shen, H. M., Hackett, J., Rogerson, B., and Martin, T. E., Cis-acting sequences that affect somatic hypermutation of Ig genes, Immunol. Rev., 162, 153-160, 1998.
155. Klotz, E., Kim, N., Shen, H. M., Kage, K., Rogerson, B., and Martin, T. E., Somatic hypermutation of immunoglobulin genes is linked to transcription, Curr. Top. Microbiol. Immunol., 229, 11-19, 1998.
156. Falkner, F. G. and Zachau, H. G., Correct transcription of an immunoglobulin κ gene requires an upstream fragment containing conserved sequence elements, Nature, 310, 71-74, 1984.
157. Foster, J., Stafford, J., and Queen, C., An immunoglobulin promoter displays cell-type specificity independently of the enhancer, Nature, 315, 423-425, 1985.
158. Wirth, T., Staudt, L., and Baltimore, D., An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity, Nature, 329, 174-178, 1987.
159. Eaton, S. and Calame, K., Multiple DNA sequence elements are necessary for the function of an immunoglobulin heavy chain promoter, Proc. Natl. Acad. Sci. U.S.A., 84, 7634-7638, 1987.
160. Staudt, L. M., Singh, H. R. S., Wirth, T., Sharp, P. A., and Baltimore, D., A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes, Nature, 323, 640-643, 1986.
161. Staudt, L. M., Cler, R. G., Singh, H., LeBowitz, J. H., Sharp, P. A., and Baltimore, D., Cloning of a lymphoid-specific cDNA encoding a protein binding the regulatory octamer DNA motif, Science, 241, 577-580, 1988.
162. Singh, H., Sen, R., Baltimore, D., and Sharp, P. A., A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes, Nature, 319, 154-158, 1986.
163. Müller, M. M., Ruppert, S., Schaffner, W., and Matthias, P., A cloned octamer transcription factor stimulates transcription from lymphoid-specific promoters in non-B cells, Nature, 336, 544-551, 1988.
164. Verrijzer, C. P. and Van der Vliet, P. C., POU domain transcription factors, Biochim. Biophys. Acta, 1173, 1-21, 1993.
165. Herr, W. and Cleary, M. A., The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain, Genes Dev., 9, 1679-1693, 1995.
166. Poellinger, L. and Roeder, R. G., Octamer transcription factors 1 and 2 each bind to different functional elemenets in the immunoglobulin heavy-chain promoter, Mol. Cell. Biol., 9, 747-756, 1989.
167. Stern, S., Tanaka, M., and Herr, W., The Oct-1 homeodomain directs formation of a multiprotein-DNA complex with the HSV transactivator VP16, Nature, 341, 624-630, 1989.
168. Gstaiger, M., Knoepfel, L., Georgiev, O., Schaffner, W., and Hovens, C. M., A B-cell coactivator of octamer-binding transcription factors, Nature, 373, 360-362, 1995.
169. Gstaiger, M., Georgiev, O., van Leeuwen, H., van der Vliet, P., and Schaffner, W., The B-cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation, EMBO J., 15, 2781-2790, 1996.
170. Strubin, M., Newell, J. W., and Matthias, P., OBF-1, a novel B-cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins, Cell, 80, 497-506, 1995.
171. Luo, Y. and Roeder, R. G., Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B, Mol. Cell. Biol., 15, 4115-4124, 1995.
172. Tanaka, M. and Herr, W., Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation, Cell, 60, 375-386, 1990.
173. Tanaka, M., Clouston, W. M., and Herr, W., The Oct-2 glutamine-rich and proline-rich activation domains can synergize with each other or duplicates of themselves to activate transcription, Mol. Cell. Biol., 14, 6046-6055, 1994.
174. Tanaka, M. and Herr, W., Reconstitution of transcriptional activation domains by reiteration of short peptide segments reveals the modular organization of a glutamine-rich activation domain, Mol. Cell. Biol., 14, 6056-6067, 1994.
175. Corcoran, L. M., Karvelas, M., Nossal, G. J., Ye, Z. S., Jacks, T., and Baltimore, D., Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival, Genes Dev., 7, 570-582, 1993.
176. Corcoran, L. M. and Karvelas, M., Oct-2 is required early in T-cell-independent B cell activation for G1 progression and for proliferation, Immunity, 1, 635-645, 1994.
177. Luo, Y., Fujii, H., Gerster, T., and Roeder, R. G., A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors, Cell, 71, 231-241, 1992.
178. Kim, U., Qin, X.-F., Gong, S., Stevens, S., Lou, Y., Nussenzweig, M., and Roeder, R. G., The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes, Nature, 383, 542-547, 1996.
179. Schubart, D. B., Rolink, A., Kosco-Vilbois, M., Botteri, F., and Matthias, P., B-cell-specific coactivator OBF/OCA-B/Bob-1 required for immune response and germinal center formation, Nature, 383, 538-542, 1996.
180. Nielsen, P. J., Georgiev, O., Lorenz, B., and Schaffner, W., B lymphocytes are impaired in mice lacking the transcriptional coactivator Bob1/OCA-B/ OBF1, Eur. J. Immunol., 26, 3214-3218, 1996.
181. Qin, X. F., Reichlin, A., Luo, Y., Roeder, R. G., and Nussenzweig, M. C., OCA-B integrates B-cell antigen receptor-, CD40L-, and IL-4-mediated signals for the germinal center pathway of B-cell development, EMBO J., 17, 5066-5075, 1998.
182. Jenuwein, T. and Grosschedl, R., Complex pattern of immunoglobulin mu gene expression in normal and transgenic mice: nonoverlapping regulatory sequences govern distinct tissue specificities, Genes Dev., 5, 932-943, 1991.
183. Sigvardsson, M., Bemark, M., and Leanderson, T., Stimulation of kappa transcription by a decamer-dependent, synergistic mechanism, Eur. J. Immunol., 25, 298-301, 1995.
184. Atchison, M. L., Delmas, V., and Perry, R. P., A novel upstream element compensates for an ineffectual octamer in an immunoglobulin Vκ promoter, EMBO J., 1990; 9, 3109-3117, 1990.
185. Atchison, M. L., Delmas, V., and Perry, R. P., A novel upstream element compensates for an ineffectual octamer in an immunoglobulin Vκ promoter, EMBO J., 1990; 9, 3109-3117, 1990.
186. Kemler, I., Schreiber, E., Müller, M. M., Matthias, P., and Schaffner, W., Octamer transcription factors bind to two different sequence motifs of the immunoglobulin heavy chain promoter, EMBO J., 8, 2001-2008, 1989.
187. LeBowitz, J. H., Clerc, R., G., Brenowitz, M., and Sharp, P. A., The Oct-2 protein binds cooperatively to adjacent octamer sites, Genes Dev., 3, 1625-1638, 1989.
188. Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S., Nishio, Y., Nakajima, T., Hirano, T., and Kishimoto, T., A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family, EMBO J., 9, 1897-1906, 1990.
189. Cooper, C., Johnson, D., Roman, C., Avitahl, N., Tucker, P., and Calame, K., The C/EBP family of transcriptional activators is functionally important for Ig VH promoter activity in vivo and in vitro, J. Immunol., 149, 3225-3231, 1992.
190. Sigvardsson, M., Bemark, M., and Leanderson, T., Pentadecamer-binding proteins: definition of two independent protein-binding sites needed for functional activity, Mol. Cell. Biol., 15, 1343-1352, 1995.
191. Sigvardsson, M., Akerblad, P., and Leanderson, T., Early B-cell factor interacts with a subset of kappa promoters, J. Immunol., 156, 3788-3796, 1996.
192. Liberg, D., Sigvardsson, M., Bemark, M., and Leanderson, T., Differentiation-specific, octamer-dependent costimulation of kappa transcription, J. Immunol., 160, 3899-907, 1998.
193. Högbom, E., Magnusson, A.-C., and Lenderson, T., Functional modularity in the SP6 κ promoter, Nucleic Acids Res., 19, 4347-4354, 1991.
194. Bemark, M. and Leanderson, T., Diverse transcription factors are involved in the quantitative regulation of transcriptional activation of κ transcription, Eur. J. Immunol., 27, 1308-1318, 1997.
195. Neurath, M. F., Strober, W., and Wakatsuki, Y., The murine Ig 3′ alpha enhancer is a target site with represser function for the B-cell lineage-specific transcription factor BSAP (NF-HB, S alpha-BP), J. Immunol., 153, 730-742, 1994.
196. Rinkenberger, J. L., Wallin, J. J., Johnson, K. W., and Koshland, M. E., An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene, Immunity, 5, 377-386, 1996.
197. Neuberger, M. S., Expression and regulation of an immunoglobulin heavy chain gene transfected into lymphoid cells, EMBO J., 2, 1373-1378, 1983.
198. Banerji, J., Olson, L., and Schaffner, W., A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes, Cell, 33, 729-740, 1983.
199. Gillies, S. D., Morrison, S. L., Oi, V. T., and Tonegawa, S., A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene, Cell, 33, 717-728, 1983.
200. Gerster, T., Matthias, P., Thali, M., Jiricny, J., and Scaffner, W., Cell type-specificity elements of the immunoglobulin heavy chain gene enhancer, EMBO J., 6, 1323-1330, 1987.
201. Forrester, W. C., van Genderen, C., Jenuwein, T., and Grosschedl, R., Dependence of enhancer-mediated transcription of the immunoglobulin mu gene on nuclear matrix attachment regions, Science, 265, 1221-1225, 1994.
202. Murre, C., Voronova, A., and Baltimore, D., B-cell- and myocyte-specific E2-box-binding factors contain E12/E47-like subunits, Mol. Cell. Biol., 11, 1156-1160, 1991.
203. Henthorn, P., Kiledjian, M., and Kadesch, T., Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif, Science, 247, 467-470, 1990.
204. Beckmann, H., Su, L. K., and Kadesch, T., TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer muE3 motif, Genes Dev., 4, 167-179, 1990.
205. Nelsen, B., Tian, G., Erman, B., Gregoire, J., Maki, R., Graves, B., and Sen, R., Regulation of lymphoid-specific immunoglobulin μ heavy chain gene enhancer by ETS-domain proteins, Science, 261, 82-86, 1993.
206. Kiledjian, M., Su, L. K., and Kadesch, T., Identification and characterization of two functional domains within the murine heavy-chain enhancer, Mol. Cell. Biol., 8, 145-152, 1988.
207. Nikolajczyk, B. S., Nelsen, B., and Sen, R., Precise alignment of sites required for mu enhancer activation in B cells, Mol. Cell. Biol., 16, 4544-4554, 1996.
208. Dang, W., Sun, X. H., and Sen, R., ETS-mediated cooperation between basic helix-loop-helix motifs of the immunoglobulin mu heavy-chain gene enhancer, Mol. Cell. Biol., 18, 1477-1488, 1998.
209. Erman, B., Cortes, M., Nikolajczyk, B. S., Speck, N. A., and Sen, R., ETS-core binding factor: a common composite motif in antigen receptor gene enhancers, Mol. Cell. Biol., 18, 1322-1330, 1998.
210. Nelsen, B., Kadesch, T., and Sen, R., Complex regulation of the immunoglobulin mu heavy-chain gene enhancer: microB, a new determinant of enhancer function, Mol. Cell. Biol., 10, 3145-3154, 1990.
211. Grosschedl, R. and Baltimore, D., Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements, Cell, 41, 885-897, 1985.
212. Cockerill, P. N. and Garrard, W. T., Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites, Cell, 44, 273-282, 1986.
213. Cockerill, P. N., Yuen, M.-H., and Garrard, W. T., The enhancer of the immunoglobulin heavy chain locus is flanked by presumptive chromosomal loop anchorage elements, J. Biol. Chem., 262, 5394-5397, 1987.
214. Boulikas, T., Nature of DNA sequences at the attachment regions of genes to the nuclear matrix, J. Cell. Biochem., 52, 14-22, 1993.
215. Herrscher, R. F., Kaplan, M. H., Lelsz, D. L., Das, C., Scheuermann, R., and Tucker, P. W., The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific transactivator that describes a new DNA-binding protein family, Genes Dev., 9, 3067-3082, 1995.
216. Jenuwein, T., Forrester, W. C., Qiu, R. G., and Grosschedl, R., The immunoglobulin mu enhancer core establishes local factor access in nuclear chromatin independent of transcriptional stimulation, Genes Dev., 7, 2016-2032, 1993.
217. Jenuwein, T., Forrester, W. C., Fernandez-Herrero, L. A., Laible, G., Dull, M., and Grosschedl, R., Extension of chromatin accessibility by nuclear matrix attachment regions, Nature, 385, 269-272, 1997.
218. Snapper, C. M., Marcu, K. B., and Zelazowski, P., The immunoglobulin class switch: beyond "accessibility", Immunity, 6, 217-223, 1997.
219. Manis, J. P., van der Stoep, N., Tian, M., Ferrini, R., Davidson, L., Bottaro, A., and Alt, F. W., Class switching in B cells lacking 3′ immunoglobulin heavy chain enhancers, J. Exp. Med., 188, 1421-1431, 1998.
220. Dariavach, P., Williams, G. T., Campell, K., Pettersson, S., and Neuberger, M. S., The mouse IgH 3′-enhancer, Eur. J. Immunol., 21, 1499-1504, 1991.
221. Arulampalam, V., Grant, P. A., Samuelsson, A., Lendahl, U., and Pettersson, S., Lipopolysaccharide-dependent transactivation of the temporally regulated immunoglobulin heavy chain 3′ enhancer, Eur. J. Immunol., 24, 1671-1677, 1994.
222. Arulampalam, V., Furebring, C., Samuelsson, A., Lendahl, U., Borrebaeck, C., Lundkvist, I., and Pettersson, S., Elevated expression levels of an Ig transgene in mice links the IgH 3′ enhancer to the regulation of IgH expression, Int. Immunol., 8, 1149-1157, 1996.
223. Arulampalam, V., Eckhardt, L., and Pettersson, S., The enhancer shift: a model to explain the developmental control of IgH gene expression in B-linage cells, Immunol. Today, 18, 549-554, 1997.
224. Meyer, K. B., Skogberg, M., Margenfeld, C., Ireland, J., and Pettersson, S., Repression of the immunoglobulin heavy chain 3′ enhancer by helixloop-helix protein Id 3 via a functionally important E47/E12 binding site: implication for developmental control of enhancer function, Eur. J. Immunol., 25, 1770-1777, 1995.
225. Grant, P. A., Arulampalam, V., Ahrlund-Richter, L., and Petterson, S., Identification of Ets-like lymphoid specific elements within the immunoglobulin heavy chain 3′ enhancer, Nucl. Acids Res., 17, 4401-4408, 1992.
226. Grant, P. A., Thompson, C. B., and Petterson, S., IgM receptor-mediated transactivation of the IgH 3′ enhancer couples a novel elf-1-AP-1 protein complex to the developmental control of enhancer function, EMBO J., 14, 4501-4513, 1995.
227. Singh, M. and Birshtein, B. K., NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3′ alpha enhancer at early stages of B-cell differentiation, Mol. Cell. Biol., 13, 3611-3622, 1993.
228. Schlissel, M. S. and Baltimore, D., Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription, Cell, 58, 1001-1007, 1989.
229. Schlissel, M. S., Corcoran, L. M., and Baltimore, D., Virus-transformed pre-B cells show ordered activation but not inactivation of immunoglobulin gene rearrangement and transcription, J. Exp. Med., 1763, 711, 1991.
230. Queen, C. and Stafford, J., Fine mapping of an immunoglobulin gene activator, Mol. Cell. Biol., 4, 1042-1049, 1984.
231. Queen, C. and Baltimore, D., Immunoglobulin gene transcription is activated by downstream sequence elements, Cell, 33, 741-748, 1983.
232. Picard, D. and Schaffner, W., A lymphocyte-specific enhancer in the mouse immunoglobulin κ gene, Science, 307, 80-82, 1984.
233. Meyer, K. B. and Neuberger, M. S., The immunoglobulin κ locus contain a second, stronger B-cell-specific enhancer which is located downstream of the constant region, EMBO J., 8, 1959-1964, 1989.
234. Sen, R. and Baltimore, D., Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a post-translational mechanism, Cell, 47, 921-928, 1986.
235. Atchison, M. L. and Perry, R. P., The role of the κ enhancer and its binding factor NF-κB in the developmental regulation of κ gene transcription, Cell, 48, 121-128, 1987.
236. Lenardo, M., Pierce, J. W., and Baltimore, D., Protein-binding sites in the Ig gene enhancers determine transcriptional activity and inducibility, Science, 236, 1573-1577, 1987.
237. Sen, R. and Baltimore, D., Multiple nuclear factors interact with the immunoglobulin enhancer sequences, Cell, 46, 705-716, 1986.
238. Baeuerle, P. A. and Baltimore, D., NF-κB: Ten years after, Cell, 87, 13-20, 1996.
239. Gerondakis, S., Grumont, R., Rourke, I., and Grossmann, M., The regulation and roles of Rel/NF-kappa B transcription factors during lymphocyte activation, Curr. Opin. Immunol., 10, 353-359, 1998.
240. Ghosh, S., May, M. J., and Kopp, E. B., NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses, Annu. Rev. Immunol., 16, 225-260, 1998.
241. May, M. J. and Ghosh, S., Signal transduction through NF-kappa B, Immunol. Today, 19, 80-88, 1998.
242. Baeuerle, P. A. and Baltimore, D., IκB: A specific inhibitor of the NF-κB transcription factor, Science, 242, 540-546, 1988.
243. Whiteside, S. T. and Israel, A., I kappa B proteins: structure, function, and regulation, Semin. Cancer Biol., 8, 75-82, 1997.
244. Shaffer, A. L., Peng, A., and Schlissel, M. S., In vivo occupancy of the κ light chain enhancers in primary pro- and pre-B cells: a model for the κ locus activation, Immunity, 6, 131-143, 1997.
245. Takeda, S., Zou, Y. R., Bluethmann, H., Kitamura, D., Muller, U., and Rajewsky, K., Deletion of the immunoglobulin kappa chain intron enhancer abolishes kappa chain gene rearrangement in cis but not lambda chain gene rearrangement in trans, EMBO J., 12, 2329-2336, 1993.
246. Xu, Y., Davidson, L., Alt, F. W., and Baltimore, D., Deletion of the Ig kappa light chain intronic enhancer/ matrix attachment region impairs but does not abolish V kappa J kappa rearrangement, Immunity, 4, 377-385, 1996.
247. Pongubala, J. M. R. and Atchison, M. L., Functional characterization of the developmentally controlled immunoglobulin kappa 3′ enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors, Mol. Cell. Biol., 11, 1040-1047, 1991.
248. Meyer, K. B., Sharpe, M. J., Surani, M. A., and Nueberger, M. S., The importance of the 3′-enhancer region in immunoglobulin κ gene expression, Nucl. Acids Res., 18, 5609-5615, 1990.
249. Hiramatsu, R., Akagi, K., Matsuoka, M., Sakumi, K., Nakamura, H., Kingsbury, L., David, C., Hardy, R. R., Yamamura, K., and Sakano, H., The 3′ enhancer region determines the B/T specificity and pro-B/pre-B specificity of immunoglobulin V kappa-J kappa joining, Cell, 83, 1113-1123, 1995.
250. Gorman, J. R., van der Stoep, N., Monroe, R., Cogne, M., Davidson, L., and Alt, F. W., The Ig(kappa) enhancer influences the ratio of Ig(kappa) versus Ig(lambda) B lymphocytes, Immunity, 5, 241-252, 1996.
251. van der Stoep, N., Gorman, J. R., and Alt, F. W., Reevaluation of 3′Ekappa function in stage- and lineage-specific rearrangement and somatic hypermutation, Immunity, 8, 743-750, 1998.
252. Hagman, J., Rudin, C. M., Haasch, D., Chaplin, D., and Storb, U., A novel enhancer in the immunoglobulin λ locus is duplicate and functionally independent of NFκB, Genes Dev., 4, 978-992, 1990.
253. Nagulapalli, S. and Atchison, M. L., Transcription factor Pip can enhance DNA binding by E47, leading to transcriptional synergy involving multiple protein domains, Mol. Cell. Biol., 18, 4639-4650, 1998.
254. Mather, E. L., Alt, F. W., Bothwell, A. L., Baltimore, D., and Koshland, M. E., Expression of J chain RNA in cell lines representing different stages of B lymphocyte differentiation, Cell, 23, 369-378, 1981.
255. Lamson, G. and Koshland, M. E., Changes in J chain and mu chain RNA expression as a function of B cell differentiation, J. Exp. Med., 160, 877-892, 1984.
256. Lansford, R. D., McFadden, H. J., Siu, S. T., Cox, J. S., Cann, G. M., and Koshland, M. E., A promoter element that exerts positive and negative control of the interleukin-2 responsive J-chain gene, Proc. Natl. Acad. Sci. U.S.A., 89, 5966-5970, 1992.
257. McFadden, H. J. and Koshland, M. E., Interleukin-2 and interleukin-5-induced changes in the binding of regulatory factors to the J-chain gene promoter, Proc. Natl. Acad. Sci. U.S.A., 88, 11027-11031, 1991.
258. Shin, M. K. and Koshland, M. E., Ets-related protein PU.1 regulates expression of the immunoglobulin J-chain gene through a novel Ets-binding element, Genes Dev., 7, 2006-2015, 1993.
259. Sigvardsson, M., Olsson, L., Hogbom, E., and Leanderson, T., Characterization of the joining chain (J-chain) promoter, Scand. J. Immunol., 38, 411-416, 1993.
260. Matsuuchi, L., Cann, G. M., and Koshland, M. E., Immunoglobulin J chain gene from the mouse, Proc. Natl. Acad. Sci. U.S.A., 83, 456-460, 1986.
261. Wallin, J. J., Gackstetter, E. R., and Koshland, M. E., Dependence of BSAP repressor and activator functions on BSAP concentration, Science, 279, 1961-1964, 1998.
262. Åkerblad, P., Sigvardsson, M., and Leanderson, T., Early B-cell factor (EBF) downregulates immunoglobulin heavy chain intron enhancer function in a plasmacytoma cell line, Scand. J. Immunol., 44, 89, 1996.
263. Kang, C. J., Sheridan, C., and Koshland, M. E., A stage-specific enhancer of immunoglobulin J chain gene is induced by interleukin-2 in a presecretor B-cell stage, Immunity, 8, 285-295, 1998.
264. Minie, M. E. and Koshland, M. E., Accessibility of the promoter sequence in the J-chain gene is regulated by chromatin changes during B-cell differentiation, Mol. Cell. Biol., 6, 4031-4038, 1986.
265. Mucenski, M. L., McLain, K., Kier, A. B., Swerdlow, S. H., Schreiner, C. M., Miller, T. A., Pietryga, D. W., Scott, W. J., Jr., and Potter, S. S., A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis, Cell, 65, 677-689, 1991.
266. Porcher, C., Swat, W., Rockwell, K., Fujiwara, Y., Alt, F. W., and Orkin, S. H., The T-cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages, Cell, 86, 47-57, 1996.
267. Tsai, F. Y., Keller, G., Kuo, F. C., Weiss, M., Chen, J., Rosenblatt, M., Alt, F. W., and Orkin, S. H., An early hematopoietic defect in mice lacking the transcription factor GATA-2, Nature, 371, 221-226, 1994.
268. Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., and Downing, J. R., AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis, Cell, 84, 321-330, 1996.
269. Scott, E. W., Simon, M. C., Anastasi, J., and Singh, H., Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages, Science, 265, 1573-1577, 1994.
270. Olson, M. C., Scott, E. W., Hack, A. A., Su, G. H., Tenen, D. G., Singh, H., and Simon, M. C., PU.1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation, Immunity, 3, 703-714, 1995.
271. Scott, E. W., Fisher, R. C., Olson, M. C., Kehrli, E. W., Simon, M. C., and Singh, H., PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors, Immunity, 6, 437-447, 1997.
272. Georgopoulos, K., Bigby, M., Wang, J.-H., Molnar, A., Wu, P., Winandy, S., and Sharpe, A., The Ikaros gene is required for the development of all lymphoid linages, Cell, 79, 143-156, 1994.
273. Winandy, S., Wu, P., and Georgopoulos, K., A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma, Cell, 83, 289-299, 1995.
274. Sun, L., Liu, A., and Georgopoulos, K., Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development, EMBO J., 15, 5358-5369, 1996.
275. Bain, G., Maandag, E. C. R., te Riele, H. P. J., Feeney, A. J., Sheehy, A., Schlissel, M., Shinton, S. A., Hardy, R. R., and Murre, C., Both E12 and E47 allow commitment to the B cell lineage, Immunity, 6, 145-154, 1997.
276. Zhuang, Y., Cheng, P., and Weintraub, H., B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2 and HEB, Mol. Cell. Biol., 16, 2898-2905, 1996.
277. Sun, X.-H., Constitutive expression of the Id1 gene impairs mouse B cell development, Cell, 79, 893-900, 1994.
278. Benezra, R., Davis, R. L., Lockshon, D., Turner, D. L., and Weintraub, H., The protein Id: a negative regulator of helix-loop-helix DNA binding proteins, Cell, 61, 49-59, 1990.
279. Schilham, M. W. and Clevers, H., HMG box containing transcription factors in lymphocyte differentiation, Semin. Immunol., 10, 127-132, 1998.
280. Schilham, M. W., Oosterwegel, M. A., Moerer, P., Ya, J., de Boer, P. A., van de Wetering, M., Verbeek, S., Lamers, W. H., Kruisbeek, A. M., Cumano, A., and Clevers, H., Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4, Nature, 380, 711-714, 1996.
281. Thevenin, C., Nutt, S. L., and Busslinger, M., Early function of pax5 (BSAP) before the pre-B cell receptor stage of B lymphopoiesis [in process citation], J. Exp. Med., 188, 735-744, 1998.
282. Kontgen, F., Grumont, R. J., Strasser, A., Metcalf, D., Li, R., Tarlinton, D., and Gerondakis, S., Mice lacking the c-rel protooncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression, Genes Dev., 9, 1965-1977, 1995.
283. Sha, W. C., Liou, H. C., Tuomanen, E. I., and Baltimore, D., Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses, Cell, 80, 321-330, 1995.
284. Doi, T. S., Takahashi, T., Taguchi, O., Azuma, T., and Obata, Y., NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses, J. Exp. Med., 185, 953-961, 1997.
285. Snapper, C. M., Zelazowski, P., Rosas, F. R., Kehry, M. R., Tian, M., Baltimore, D., and Sha, W. C., B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germline CH transcription, and Ig class switching, J. Immunol., 156, 183-191, 1996.
286. Weih, F., Durham, S. K., Barton, D. S., Sha, W. C., Baltimore, D., and Bravo, R., p50-NF-kappaB complexes partially compensate for the absence of RelB: severely increased pathology in p50(-/-)relB(-/-) double-knockout mice, J. Exp. Med., 185, 1359-1370, 1997.
287. Burkly, L., Hession, C., Ogata, L., Reilly, C., Marconi, L. A., Olson, D., Tizard, R., Cate, R., and Lo, D., Expression of relB is required for the development of thymic medulla and dendritic cells, Nature, 373, 531-536, 1995.
288. Horwitz, B. H., Scott, M. L., Cherry, S. R., Bronson, R. T., and Baltimore, D., Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells, Immunity, 6, 765-772, 1997.
289. Franzoso, G., Carlson, L., Xing, L., Poljak, L., Shores, E. W., Brown, K. D., Leonardi, A., Tran, T., Boyce, B. F., and Siebenlist, U., Requirement for NF-kappaB in osteoclast and B-cell development, Genes Dev., 11, 3482-3496, 1997.
290. Merrell, K., Wells, S., Henderson, A., Gorman, J., Alt, F., Stall, A., and Calame, K., The absence of the transcription activator TFE3 impairs activation of B cells in vivo, Mol. Cell. Biol., 17, 3335-3344, 1997.
291. Wang, J. H., Avitahl, N., Cariappa, A., Friedrich, C., Ikeda, T., Renold, A., Andrikopoulos, K., Liang, L., Pillai, S., Morgan, B. A., and Georgopoulos, K., Aiolos regulates B-cell activation and maturation to effector state, Immunity, 9, 543-553, 1998.